한국유니온제약 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 부광약품, was filed 04 Jun 2026.
Who traded when
BuySaleSince the insiders bought
- +0.0%Entry ₩8,176 · Close at T+90 ₩8,176
- +0.0%Entry ₩2,725 · Close at T+365 ₩2,725
- +0.0%Entry ₩2,725 · Close at T+365 ₩2,725
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 60,000,000 sharesShareKRXDART:20260604000193Canonical exit: 26 Aug 2026 (T+90)
- 9,455,845 sharesKRXDART:20260526000422Canonical exit: 17 Aug 2026 (T+90)
- 9,455,845 sharesShareKRXDART:20260526000426Canonical exit: 24 Aug 2026 (T+90)
- 1,420,090 sharesKRXDART:20260309001197
- ●Executives0DART
- 3,150 sharesShareKRXDART:20241219000147Canonical exit: 19 Mar 2025 (T+90)
- ●Executives0DART
- ●Executives0DART
- 169,445 sharesKRXDART:20241118000298Canonical exit: 4 Feb 2025 (T+90)
- 720,556 sharesShareKRXDART:20241113000028Canonical exit: 11 Feb 2025 (T+90)
- 285,242 sharesShareKRXDART:20241112000464Canonical exit: 10 Feb 2025 (T+90)
- 1,165,798 sharesKRXDART:20241112000456Canonical exit: 4 Feb 2025 (T+90)
- 0KRXDART:20241112000460
- 1,165,798 sharesKRXDART:20240821000335
- 408,500 sharesKRXDART:20240821000345
- ShareKRXDART:20240821000387
- ShareKRXDART:20240821000363
- 1,773,550 sharesKRXDART:20240806000214
- 0KRXDART:20240805000270
- 0KRXDART:20240805000255
- 1,868,679 sharesKRXDART:20240524000277Canonical exit: 18 Aug 2024 (T+90)
- 0KRXDART:20240524000488
- 0KRXDART:20240524000497
- 0KRXDART:20240520000241
25 of 72 declarations
About 한국유니온제약
안희숙 alone writes 50 of the 71 filings at 한국유니온제약: 2 purchases, 2 sales, the rest unrelated to a trade. Among other filers, 신성희 and 황용문 (both 대량보유자) each have one purchase and one sale, 박광석 2 purchases, and the company 2 filings with no trade. No amount is stated. In all, 10 purchases and 6 sales, or 63% purchases.
From November 6 to November 13, 2024, 3 distinct filers bought. Filings were published from August 4, 2021 to June 4, 2026: 4 in 2021, 16 in 2022, 23 in 2023 and in 2024, then only 1 in 2025 and 4 in 2026. As many as 55 filings are neither purchases nor sales.
Read moreShow less
The South Korean health care business is capitalised at KRW 217.0 billion; insiders (9 filers) hold 33.2% of it. Filings come out a median of 6 days after the trade, and the latest year has 4 filings (3 purchases, 1 sale).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
